Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study.
Tünbekici S, Yuksel HC, Acar C, Sahin G, Orman S, Majidova N, Coskun A, Seyyar M, Dilek MS, Kara M, Dıslı AK, Demir T, Kolkıran N, Sahbazlar M, Demırcıler E, Kuş F, Aytac A, Menekse S, Yucel H, Biter S, Koseci T, Unsal A, Ozveren A, Sevınc A, Goker E, Gürsoy P. Tünbekici S, et al. Among authors: aytac a. Cancers (Basel). 2024 Dec 27;17(1):46. doi: 10.3390/cancers17010046. Cancers (Basel). 2024. PMID: 39796675 Free PMC article.
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Özyurt N, Alkan A, Gülbağcı B, Seyyar M, Aydın E, Şahbazlar M, Türker M, Kınıkoğlu O, Yerlikaya T, Dinç G, Aytaç A, Kalkan Z, Ebinç S, Gültürk İ, Keskinkılıç M, İşleyen ZS, Çağlayan D, Türkel A, Aydın E, Şakalar T, Sekmek S, Yıldırım N, Koçak S, Okutur K, Özveren A, Dursun B, Kitaplı S, Eren OÖ, Beypınar İ, Hacıbekiroğlu İ, Çabuk D, Karaman E, Acar Ö, Paydaş S, Eryılmaz MK, Demir B, Oruç Z, Yılmaz M, Biricik FS, Salim DK, Tanrıverdi Ö, Doğan M. Özyurt N, et al. Among authors: aytac a. Sci Rep. 2024 Oct 9;14(1):23556. doi: 10.1038/s41598-024-75293-5. Sci Rep. 2024. PMID: 39384975 Free PMC article.
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer.
Seber ES, Iriagac Y, Cavdar E, Karaboyun K, Avci O, Yolcu A, Gurdal SO, Oznur M, Ekinci F, Aytac A, Gulturk I, Yilmaz M, Sever N, Kapagan T, Ferhatoglu F, Kahvecioglu FA, Hacibekiroglu I. Seber ES, et al. Among authors: aytac a. J Coll Physicians Surg Pak. 2024 Jan;34(1):37-41. doi: 10.29271/jcpsp.2024.01.37. J Coll Physicians Surg Pak. 2024. PMID: 38185958
88 results